4.6 Review

Diet and gut microbiome in fatty liver and its associated liver cancer

期刊

出版社

WILEY
DOI: 10.1111/jgh.15713

关键词

diet; gut microbiome; HCC; NASH

资金

  1. National Natural Science Foundation of China [82103355]
  2. RGC Theme-based Research Scheme Hong Kong [T12-703/19R]
  3. Health and Medical Research Fund, Hong Kong [08191336]
  4. CUHK direct grant

向作者/读者索取更多资源

Non-alcoholic fatty liver disease (NAFLD) is a major cause of chronic liver disease worldwide, with the gut microbiome and dietary components playing important roles in its development and its related hepatocellular carcinoma (HCC). Components in the diet such as cholesterol, fiber, fat, and sugar can alter the gut microbiome composition, consequently affecting the progression of NAFLD and related conditions.
Non-alcoholic fatty liver disease (NAFLD) is the major cause of chronic liver disease worldwide as a consequence of a sedentary lifestyle and overnutrition. NAFLD could progress to non-alcoholic steatohepatitis (NASH), which may further develop to cirrhosis and hepatocellular carcinoma (HCC). The gut microbiome is one of the central regulators in host metabolism. Diet could change human gut microbiome rapidly and reproducibly and modulate several metabolic pathways. Both diet and gut microbiome dysbiosis are associated with NAFLD and its related HCC (NAFLD-HCC). Dietary cholesterol, fiber, fat, or carbohydrate could change the microbiome composition to contribute to the development of NASH and NAFLD-HCC. Hence, identification of elements of the gut-liver axis that are primarily damaged in NASH and NAFLD-HCC offers new possibility for therapeutic intervention. In this review, the roles of gut microbiome and microbial metabolites in the development and progression of NAFLD and NAFLD-HCC are first discussed. The impacts of different diet compositions including cholesterol, fiber, fat, and sugar on the gut microbiome that leads to predisposition to NASH and NAFLD-HCC are also explored. We summarized the article by discussing potential therapeutic implication of diet and microbiome modulation in fatty liver and liver cancer.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据